{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1146.1632","meta":{"versionId":"6","lastUpdated":"2022-01-18T01:02:48.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CSTE Author"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-keyWord","valueString":"Hepatitis_C,Trigger"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2022-01-18"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1632","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1146.1632"}],"version":"20220118","name":"GlecaprevirPibrentasvirCombinationRXNORM","title":"Glecaprevir Pibrentasvir Combination (RXNORM)","status":"active","experimental":false,"date":"2022-01-18T01:02:48-05:00","publisher":"CSTE Steward","description":"All prescribable medication formulations represented using either a \"generic\" or \"brand-specific\" concept. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), or SBD (semantic brand drug). GPCK (generic pack), BPCK (brand pack), SCDG (semantic clinical drug group), SBDG (semantic brand drug group), SCDF (semantic clinical drug form), IN (ingredient) or SBDF (semantic brand drug form) are NOT included in this value set.","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This set of values contains codes for prescribable medications with Glecaprevir Pibrentasvir),(Data Element Scope: Medications that were administered, ordered or prescribed.),(Inclusion Criteria: Glecaprevir Pibrentasvir),(Exclusion Criteria: SBDG (semantic brand drug group), SCDF (semantic clinical drug form), or SBDF (semantic brand drug form).)","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","concept":[{"code":"1940703","display":"glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet"},{"code":"1940709","display":"glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret]"},{"code":"2557906","display":"glecaprevir 50 MG / pibrentasvir 20 MG Oral Pellet"},{"code":"2557910","display":"glecaprevir 50 MG / pibrentasvir 20 MG Oral Pellet [Mavyret]"}]}]},"expansion":{"identifier":"urn:uuid:ebeed7e5-80d2-4123-8479-07652a9fbf25","timestamp":"2023-12-10T22:02:56-05:00","total":4,"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1940703","display":"glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"1940709","display":"glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet [Mavyret]"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2557906","display":"glecaprevir 50 MG / pibrentasvir 20 MG Oral Pellet"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"11062023","code":"2557910","display":"glecaprevir 50 MG / pibrentasvir 20 MG Oral Pellet [Mavyret]"}]}}